Bicara Therapeutics BCAX State
State at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit.
The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's state.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bicara Therapeutics's state?
- Bicara Therapeutics (BCAX) reported state of $0 in Q4 2025.
- What does state mean?
- This metric reflects the impact of temporary differences between financial and tax accounting specifically at the state and local level. It represents the deferred tax consequences that will reverse in future periods within regional jurisdictions. It provides insight into the long-term state tax profile of the organization.